RECRUITING

Influences of High-fiber, Organic Whole-food Formula on the Gut Microbiome in Critically Ill Children

Description

This study evaluates the effects of either Pediasure or Nourish formulas on the gastrointestinal microbiome in critically-ill children. Patients will be randomized to received either Pediasure or Nourish.

Conditions

Critical IllnessDysbiosisPediatric ALL
Talk to us

Related Conditions:

Critical IllnessDysbiosisPediatric ALL

Study Overview

On this page

Study Details

Study overview

This study evaluates the effects of either Pediasure or Nourish formulas on the gastrointestinal microbiome in critically-ill children. Patients will be randomized to received either Pediasure or Nourish.

Influences of High-fiber, Organic Whole-food Formula on the Gut Microbiome in Critically Ill Children

Influences of High-fiber, Organic Whole-food Formula on the Gut Microbiome in Critically Ill Children

Condition
Critical Illness
Intervention / Treatment

-

Contacts and Locations

Pittsburgh

Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, United States, 15224

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Admitted to the pediatric intensive care unit
  • * Age 1-17 years old
  • * Previously placed enteric tube designed for enteric feeding
  • * Vasoactive medication use
  • * History of allergies or intolerances to either Pediasure or Nourish
  • * Whey allergy or intolerance
  • * Gluten sensitivity or intolerance
  • * Medical condition that necessitate the use of specific formulas and/or nutritional needs (e.g. epilepsy requiring ketogenic diet, genetic metabolic dysfunction with specific formula requirements)

Ages Eligible for Study

1 Year to 17 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Pittsburgh,

Raj Aneja, MD, PRINCIPAL_INVESTIGATOR, University of Pittsburgh Medical Center

Study Record Dates

2025-08